Replenix Gly-Sal 2-2
- Product NDC
- 51326-925
- 11-digit product format
- 513260925
- Labeler code
- 51326
- Product ID
- 51326-925_d8528811-6b8f-4332-96c2-753657502234
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- salicylic acid
- Dosage form
- LIQUID
- Route
- TOPICAL
- Labeler
- Topiderm, Inc.
- Application
- M006
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2019-07-23
- Substance
- SALICYLIC ACID
- Active strength
- 20 mg/mL
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Replenix Gly-Sal 2-2
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| SALICYLIC ACID | 20 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | O414PZ4LPZ |
| Rxcui | 562600 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 51326-925-01 | Replenix Gly-Sal 2-2 | 200 mL in 1 BOTTLE | LIQUID | 200 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51326-925 | REPLENIX GLY-SAL 2-2 (SALICYLIC ACID) LIQUID [TOPIDERM, INC.] | 1 | Current NDC, 1 package rows | 20240726_6c6bbedc-e2ee-46a0-8800-e356bdd262b0.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 51326-925-01 | 51326092501 | 200 mL in 1 BOTTLE (51326-925-01) | 200 ml | 2019-07-23 | No | No | Current |